Banco Santander, S.A. : Good timing to anticipate a continuation of the trend
Entry price | Target | Stop-loss | Potential |
---|
€3.41 |
€4.05 |
€2.95 |
+18.77% |
---|
Banco Santander, S.A.'s shares display attractive technical aspects to anticipate a comeback of the underlying trend.
SummaryStrengths● Its low valuation, with P/E ratio at 9.92 and 8.6 for the ongoing fiscal year and 2022 respectively, makes the stock pretty attractive with regard to earnings multiples.
●
● This company will be of major interest to investors in search of a high dividend stock.
● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
● For several months, analysts have been revising their EPS estimates roughly upwards.
●
●
● Historically, the company has been releasing figures that are above expectations.
Weaknesses● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
●
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.